E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/13/2005 in the Prospect News Biotech Daily.

Immucor adds 1 million shares to stock buyback program

New York, Dec. 13 - Immucor, Inc. said its board of directors has increased its stock repurchase program by 1 million shares.

"We have seen our cash balance grow significantly, weighed our alternatives and believe the best way to enhance shareholder value is by re-purchasing stock," said Gioacchino De Chirico, president of Immucor, in a news release.

The directors authorized the company to resume purchases under the old program on Nov. 11.

Since that time it has bought back 742,600 shares. With the extra 1 million share authorization, Immucor can now buy up to 1,260,150 shares.

Immucor is a Norcross, Ga., manufacturer of reagents and systems to identify cell and serum components of blood. Its stock closed at $24.50 on Tuesday.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.